ChanRx Inks Series A

Cleveland-based ChanRx has closed on an undisclosed amount of Series A financing from investors including Sante Ventures. The company is developing drugs to treat atrial fibrillation. Sante Ventures was founded in 2006 and manages $260 million in capital.

North AmericaUSBriefs